Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.orchidpharma.com | |
Market Cap | 1,542.86 Cr. | |
Enterprise Value(EV) | 1,910.30 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -4.75 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-12 |
Industry PE | 31.71 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 155.99 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 2.42 | Calculated using Price: 378.00 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 4.08 Cr. | 40,816,400 Shares |
FaceValue | 10 | |
Company Profile | ||
Orchid Chemicals & Pharmaceuticals (Orchid) is pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was Incorporated in the year 1992 as a 100% export-oriented unit (EOU). |
1 Day |
|
|
1 Week |
|
-2.59% |
1 Month |
|
-8.32% |
3 Month |
|
-0.44% |
6 Month |
|
+15.34% |
1 Year |
|
+36.67% |
2 Year |
|
-77.85% |
5 Year |
|
+2850.57% |
10 Year |
|
+494.18% |
9 years | 2013-09 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | -74.06 | -55.58 | -147.51 | -423.17 | -13.43 | -8.75 | ||||
Return on Capital Employed (%) | -1.48 | 4.17 | -0.06 | -6.93 | -3.46 | 3.08 | -6.47 | -3.53 | -2.32 | |
Return on Assets (%) | -13.04 | -4.53 | -7.05 | -13.59 | -10.88 | 2.24 | -5.78 | -7.06 | -4.85 |
Particulars | 10 years | 2013-09 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 380 | 329 | 49 | -388 | -792 | -704 | 766 | 653 | 647 | 622 | |
Non Curr. Liab. | 1,064 | 2,609 | 2,475 | 2,205 | 1,905 | 1,436 | 519 | 442 | 222 | 223 | |
Curr. Liab. | 3,206 | 1,123 | 1,338 | 1,541 | 2,013 | 2,346 | 175 | 142 | 241 | 320 | |
Minority Int. | 1 | ||||||||||
Equity & Liab. | 4,651 | 4,061 | 3,862 | 3,358 | 3,125 | 3,077 | 1,460 | 1,237 | 1,111 | 1,165 | |
Non Curr. Assets | 3,550 | 2,783 | 2,611 | 2,479 | 2,446 | 2,310 | 891 | 687 | 661 | 670 | |
Curr. Assets | 1,101 | 1,278 | 1,251 | 879 | 679 | 767 | 569 | 550 | 450 | 496 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 4,651 | 4,061 | 3,862 | 3,358 | 3,125 | 3,077 | 1,460 | 1,237 | 1,111 | 1,165 |
Particulars | 10 years | 2013-09 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 1,948 | 1,747 | 873 | 797 | 683 | 600 | 484 | 450 | 560 | 634 | |
Other Income | 41 | 42 | 25 | 19 | 20 | 17 | 24 | 15 | 9 | 19 | |
Total Income | 1,988 | 1,789 | 898 | 816 | 703 | 617 | 508 | 465 | 569 | 654 | |
Total Expenditure | -1,837 | -1,429 | -703 | -709 | -659 | -612 | -515 | -399 | -505 | -566 | |
PBIDT | 151 | 360 | 196 | 106 | 45 | 5 | -7 | 66 | 64 | 88 | |
Interest | -523 | -537 | -294 | -331 | -310 | -7 | -6 | -52 | -33 | -29 | |
Depreciation | -252 | -325 | -145 | -141 | -133 | -130 | -118 | -109 | -87 | -74 | |
Taxation | 13 | 191 | 17 | 48 | 46 | ||||||
Exceptional Items | 51 | 113 | -53 | -173 | 201 | ||||||
PAT | -560 | -197 | -279 | -490 | -353 | 69 | -131 | -95 | -57 | -15 | |
Minority Interest | 2 | 1 | |||||||||
Share Associate | 0 | -4 | -2 | ||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | -558 | -197 | -279 | -490 | -353 | 70 | -131 | -117 | -2 | -19 | |
Adjusted EPS | -79 | -23 | -31 | -55 | -40 | 8 | -32 | -29 | 0 | -5 |
Particulars | 10 years | 2012-03 Rs. Cr. | 2013-09 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 737 | 168 | -369 | 212 | 317 | 9 | 12 | 81 | 24 | 92 | |
Cash Fr. Inv. | -293 | -986 | 1,334 | -1 | -9 | -28 | 45 | 167 | 67 | 113 | |
Cash Fr. Finan. | -480 | 664 | -597 | -286 | -366 | 33 | 0 | -250 | -165 | -217 | |
Net Change | -36 | -153 | 367 | -76 | -58 | 15 | 57 | -2 | -74 | -11 | |
Cash & Cash Eqvt | 177 | 23 | 391 | 315 | 257 | 35 | 92 | 90 | 16 | 4 |
Fri, 03 Mar 2023
Announcement Under Regulation 30 (LODR)- Update Announcement under Regulation 30 (LODR)- Update |
Wed, 22 Feb 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript Transcript of Investor call/earning call held on February 17 2023. |
Fri, 17 Feb 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Investor Presentation - February 17 2023 |
Mon, 20 Mar 2023 |
|
|
|
|
|